Cell replacement therapy for Parkinson's disease: how close are we to the clinic? - Wikidata - awgldk - TriplyDB

Cell replacement therapy for Parkinson's disease: how close are we to the clinic?

Cell replacement therapy for Parkinson's disease: how close are we to the clinic?

http://www.wikidata.org/entity/Q37921767

about

Sox-2 Positive Neural Progenitors in the Primate Striatum Undergo Dynamic Changes after Dopamine Denervation Dopaminergic-like neurons derived from oral mucosa stem cells by developmental cues improve symptoms in the hemi-parkinsonian rat model Cortex Fraxini (Qingpi) Protects Rat Pheochromocytoma Cells against 6-Hydroxydopamine-Induced Apoptosis Iron Deposition Leads to Neuronal α-Synuclein Pathology by Inducing Autophagy Dysfunction.Astrocyte-like cells derived from human oral mucosa stem cells provide neuroprotection in vitro and in vivo.Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage.Harnessing neurogenesis for the possible treatment of Parkinson's disease.Genetic modification of H2AX renders mesenchymal stromal cell-derived dopamine neurons more resistant to DNA damage and subsequent apoptosis.Dopaminergic cells, derived from a high efficiency differentiation protocol from umbilical cord derived mesenchymal stem cells, alleviate symptoms in a Parkinson's disease rodent model.Liver X receptors agonist promotes differentiation of rat bone marrow derived mesenchymal stem cells into dopaminergic neuron-like cells.

P2860

Q27314710-BBA667EC-2EA8-4D24-85F9-9AD2A6A53CDF Q35191399-5431C188-3575-4E27-B8FF-B79B225EC68B Q35989000-6741ACE3-6BFE-468F-8D26-9D1E19DB6C2C Q37587232-531944E1-A223-4441-9525-1C252668EC22 Q37635458-64925065-3C3C-4A30-933C-E1C58068429A Q37677012-61A54351-82E9-416D-B68D-E2E03756B00D Q38203839-14A6B40F-5857-48AD-97F9-8D98DD608892 Q40466209-E7AE0835-839D-4480-8FDD-DB434CBD82D2 Q43964216-D2E9675E-2450-4737-A010-870CD72C0229 Q50128336-95557D33-598A-4A75-84DB-B75698A346AA

P2860

Cell replacement therapy for Parkinson's disease: how close are we to the clinic?

http://www.wikidata.org/entity/Q37921767

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Cell replacement therapy for Parkinson's disease: how close are we to the clinic?

@en

Cell replacement therapy for Parkinson's disease: how close are we to the clinic?

@nl

type

label

Cell replacement therapy for Parkinson's disease: how close are we to the clinic?

@en

Cell replacement therapy for Parkinson's disease: how close are we to the clinic?

@nl

prefLabel

Cell replacement therapy for Parkinson's disease: how close are we to the clinic?

@en

Cell replacement therapy for Parkinson's disease: how close are we to the clinic?

@nl

P1433

Q37921767-57E7724B-5D35-478F-A957-A8F2A4620C44

P1476

Q37921767-6326D996-E87A-4149-B3D5-9F4C17C632FE

P2093

Q37921767-1BA074E2-69F4-408E-B3AF-F33946BDCEE1

Q37921767-7381DEF3-E268-4412-90D4-16C95B0DBEAA

Q37921767-EB6D89B2-438E-4206-97EC-56307C93436F

P2860

Q37921767-00A0F123-8D91-4E83-84FC-BE481B2C117D

Q37921767-01597313-3783-4774-A526-159A3A0B50CA

Q37921767-019C5144-FEEE-4ABC-B5E8-9F2ED10DBEED

Q37921767-06026ECC-909B-4070-BA8C-528FC5B2E4DE

Q37921767-06AB4280-8E2E-4FDA-B225-95AA67B3D825

Q37921767-0886E010-3C93-466B-8AFE-86868E48FBA3

Q37921767-153CD59B-8375-43E2-9140-62F11980E58B

Q37921767-17243408-9871-4DCF-94E9-6383FCB903C1

Q37921767-17661A82-E030-464F-9760-9B02F079DF7D

Q37921767-1C6208B7-CD83-403F-9754-156A7245B6BF

P304

Q37921767-23458F2B-B39B-40EA-9EC1-3BED3BE6BD77

P31

Q37921767-7D8101F8-F4A2-4DC0-BFB7-348F417D999F

P356

Q37921767-762555FC-CA78-4BB8-A794-3603968808E7

P433

Q37921767-12E8F3DB-7391-402A-B32B-CE1CFF221B42

P478

Q37921767-1C3AEB91-7B02-47DA-A40B-7F21A37A0A16

P50

Q37921767-13F850DC-D938-4E6C-9F3C-592D6A68B982

P577

Q37921767-D921234A-F99A-41BF-AEB6-376FF63A1EE1

P5875

Q37921767-8EB9189D-DC7E-4F08-B0E8-D11ABCB2C2E7

P698

Q37921767-C6C313D7-374E-456C-9807-9E0BAF2118CF

P921

Q37921767-5B9B2D4A-75EA-4258-9502-A210D30F68E7

P356

P1433

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

P1476

Cell replacement therapy for Parkinson's disease: how close are we to the clinic?

@en

P2093

Daniel Offen

http://www.w3.org/2001/XMLSchema#string

Eldad Melamed

http://www.w3.org/2001/XMLSchema#string

Nirit Lev

http://www.w3.org/2001/XMLSchema#string

P2860

Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype.

Direct conversion of fibroblasts to functional neurons by defined factors

Disease-specific induced pluripotent stem cells

Stem cells in human neurodegenerative disorders--time for clinical translation?

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Embryonic stem cell lines derived from human blastocysts

Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model

Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a

P304

1325-1339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERN.11.74

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51592512

http://www.w3.org/2001/XMLSchema#string

P698

21864078

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease